Trially Appoints Christian Smith as CRO to Boost AI-Driven Clinical Trial Enrollment Across the U.S.

Trially®, a trailblazing AI clinical trial recruitment technology, has announced the appointment of Christian Smith as Chief Revenue Officer (CRO). Based in Kansas City, Missouri, Trially is dedicated to accelerating qualified patient enrollment in clinical trials. Smith, a seasoned entrepreneur and healthcare veteran, will lead the company’s efforts to expand its AI solutions across the United States, providing critical support to clinical research sites, healthcare systems, and sponsors. Smith joins Trially at a crucial juncture. Clinical research sites are grappling with increasingly stringent enrollment pressures and dwindling patient pipelines. In this challenging landscape, where 68% of sites fail to meet their enrollment targets and screen failure rates are on the rise, Trially's AI tools are making a significant impact. These tools enable sites to predictively pre-screen and qualify patients for trials, regardless of whether they have an electronic health record (EHR) integration or not. This capability helps research teams multiply enrollment rates for even the most complex protocols in record time. "I've experienced firsthand the challenges of navigating medical care when standard treatments fail," said Smith. "In 2005, when my mother passed away from breast cancer, we were unaware of the 28 studies running within driving distance, including those for Trastuzumab and Bevacizumab—two of the most effective treatments available today. It is a tremendous honor to join Trially and help improve health outcomes and the standard of care by matching patients with innovative drug therapies." Smith’s background includes co-founding TrackR, where he pioneered the Bluetooth tracking category and scaled the company to over $50 million in revenue. During the COVID-19 pandemic, he managed direct-to-consumer operations at Dascena, overseeing the opening of 44 testing sites in 26 cities. Most recently, he co-founded Forta, an AI-powered family-centric autism therapy model. His experience in direct-to-patient recruitment, AI-driven care, and scaling operational excellence makes him an ideal fit for Trially. "Christian embodies the values we hold dear at Trially: efficiency, transparency, and empathy," said Trevor Welch, Co-founder and Chief Product Officer of Trially. "His passion for scaling with purpose and his commitment to empowering research teams to help patients gain access to life-saving therapies align perfectly with our mission. His appointment marks a new chapter in our drive to revolutionize clinical trial enrollment.” About Trially Trially® is redefining clinical trial recruitment with its advanced AI matching technology. By safely unlocking rich clinical data, Trially expedites the enrollment of qualified patients, achieving a 200% increase in enrollment rates and significantly reducing screen failures. The company's site-based software seamlessly integrates with any EHR or CTMS system while ensuring full compliance with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001 regulations. Trially serves physicians, research sites, and pharmaceutical sponsors, delivering exceptional results in clinical research and improving patient access to cutting-edge treatments. For more information, visit trially.ai.